Almac Group, a Craigavon, UK-based contract development and manufacturing organization, has appointed Stefan Mix, PhD, as head of biocatalysis, effective January 2, 2018.

Mix joined the Almac Sciences business in April 2005 as a chemist working in the lab on process development projects for chiral materials and has been part of the biocatalysis team since its early stages. He has gained industrial experience, including applications of biocatalysis, crystallization development, process development for chiral building blocks and active pharmaceutical ingredients, and technology transfer to manufacturing network partners. Mix was promoted to Biocatalysis team leader in 2012. Mix has played a role in developing Almac Sciences’ Biocatalysis technology platform, which has multiple applications across a range of project scales and industry sectors, according to Almac Group.

In his new role, Mix will be responsible for the development and application of platform technologies within Almac Sciences in addition to supporting and directing commercialization of new technology.

Source: Almac Group